Literature DB >> 21493601

Individual monitoring for internal contamination with plutonium compounds at JAEA-NCL.

Osamu Kurihara1, Katsuta Kanai.   

Abstract

This paper provides an outline of an individual monitoring programme for internal contamination with Pu compounds and some of the knowledge obtained from experience of inhalation incidents that occurred over the past few decades at the Japan Atomic Energy Agency, Nuclear Fuel Cycle Engineering Laboratories (JAEA-NCL). Most of the incidents resulted in minor exposure doses, being an average of 0.1 mSv at a mixed oxide plant and 1.5 mSv at a reprocessing plant. Only two incidents involving three workers resulted in exposure over the regulatory dose limits of that time. The maximum exposure dose, an effective dose equivalent of 90 mSv, was assessed for a worker involved in the incident that took place at the reprocessing plant in 1993. Only faecal measurements have been used in final dose assessments because alternative monitoring data have rarely been available. Further investigations on the physicochemical properties specific to Pu compounds in workplaces have therefore been needed to improve not only the accuracy of internal dose assessments but also the nasal swab method useful in deciding medical intervention.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21493601     DOI: 10.1093/rpd/ncr139

Source DB:  PubMed          Journal:  Radiat Prot Dosimetry        ISSN: 0144-8420            Impact factor:   0.972


  2 in total

1.  Detection of alpha particle emitters originating from nuclear fuel inside reactor building of Fukushima Daiichi Nuclear Power Plant.

Authors:  Yuki Morishita; Tatsuo Torii; Hiroshi Usami; Hiroyuki Kikuchi; Wataru Utsugi; Shiro Takahira
Journal:  Sci Rep       Date:  2019-01-24       Impact factor: 4.379

2.  Organ Dose Reconstruction Applicable for a Japanese Nuclear Worker Cohort: J-EPISODE.

Authors:  Hiroshige Furuta; Kaoru Sato; Akemi Nishide; Shin'ichi Kudo; Shin Saigusa
Journal:  Health Phys       Date:  2021-11-01       Impact factor: 1.316

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.